Drug resistance remains a major challenge in epilepsy, and overexpression of ATP-binding cassette transporters, particularly P-glycoprotein (P-gp), at the blood-brain barrier (BBB) has been consistently implicated in limiting central nervous system drug exposure. Here, PGP is linked to epilepsy.